- Section 1 Patients and their treatment
- Section 2 Background to medicine
- Section 3 Cell biology
- Section 4 Immunological mechanisms
- Section 5 Principles of clinical oncology
- Section 6 Old age medicine
- Section 7 Pain and palliative care
- Section 8 Infectious diseases
- 8.1 Pathogenic microorganisms and the host
- 8.2 The patient with suspected infection
- 8.3 Immunization
- 8.4 Travel and expedition medicine
- 8.5 Viruses
- 8.6 Bacteria
- 8.7 Fungi (mycoses)
- 8.8 Protozoa
- 8.8.1 Amoebic infections
- 8.8.2 Malaria
- 8.8.3 Babesiosis
- 8.8.4 Toxoplasmosis
- 8.8.5 <i>Cryptosporidium</i> and cryptosporidiosis
- 8.8.6 <i>Cyclospora</i> and cyclosporiasis
- 8.8.7 Cystoisosporiasis
- 8.8.8 Sarcocystosis (sarcosporidiosis)
- 8.8.9 Giardiasis and balantidiasis
- 8.8.10 <i>Blastocystis</i> infection
- 8.8.11 Human African trypanosomiasis
- 8.8.12 Chagas disease
- 8.8.13 Leishmaniasis
- 8.8.14 Trichomoniasis
- 8.9 Nematodes (roundworms)
- 8.10 Cestodes (tapeworms)
- 8.11 Trematodes (flukes)
- 8.12 Nonvenomous arthropods
- 8.13 Pentastomiasis (porocephalosis, linguatulosis/linguatuliasis, or tongue worm infection)
- Section 9 Sexually transmitted diseases
- Section 10 Environmental medicine, occupational medicine, and poisoning
- Section 11 Nutrition
- Section 12 Metabolic disorders
- Section 13 Endocrine disorders
- Section 14 Medical disorders in pregnancy
- Section 15 Gastroenterological disorders
- Section 16 Cardiovascular disorders
- Section 17 Critical care medicine
- Section 18 Respiratory disorders
- Section 19 Rheumatological disorders
- Section 20 Disorders of the skeleton
- Section 21 Disorders of the kidney and urinary tract
- Section 22 Haematological disorders
- Section 23 Disorders of the skin
- Section 24 Neurological disorders
- Section 25 Disorders of the eye
- Section 26 Psychiatric and drug-related disorders
- Section 27 Forensic medicine
- Section 28 Sport and exercise medicine
- Section 29 Biochemistry in medicine
- Section 30 Acute medicine
Leishmaniasis
- Chapter:
- Leishmaniasis
- Author(s):
Antony D.M. Bryceson
, and Diana N.J. Lockwood
- DOI:
- 10.1093/med/9780198746690.003.0171
Leishmaniasis is caused by parasites of the genus Leishmania, which are transmitted to humans from human or animal reservoirs by the bites of phlebotomine sandflies. In places the disease is common and important, with perhaps 500,000 cases of visceral leishmaniasis and 1.5–2 million cases of cutaneous leishmaniasis worldwide each year. Diagnosis is by demonstration of leishmania organisms in tissue smears or biopsy material by microscopy, culture, or detecting leishmaniai DNA by polymerase chain reaction. As an imported disease, cutaneous leishmaniasis is common in travellers, military personnel, and immigrants coming from endemic areas, while the diagnosis of the less common visceral leishmaniasis is frequently overlooked. Prevention is by controlling reservoir hosts and sandfly vectors, or by avoiding bites by vectors. There is no vaccine.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Section 1 Patients and their treatment
- Section 2 Background to medicine
- Section 3 Cell biology
- Section 4 Immunological mechanisms
- Section 5 Principles of clinical oncology
- Section 6 Old age medicine
- Section 7 Pain and palliative care
- Section 8 Infectious diseases
- 8.1 Pathogenic microorganisms and the host
- 8.2 The patient with suspected infection
- 8.3 Immunization
- 8.4 Travel and expedition medicine
- 8.5 Viruses
- 8.6 Bacteria
- 8.7 Fungi (mycoses)
- 8.8 Protozoa
- 8.8.1 Amoebic infections
- 8.8.2 Malaria
- 8.8.3 Babesiosis
- 8.8.4 Toxoplasmosis
- 8.8.5 <i>Cryptosporidium</i> and cryptosporidiosis
- 8.8.6 <i>Cyclospora</i> and cyclosporiasis
- 8.8.7 Cystoisosporiasis
- 8.8.8 Sarcocystosis (sarcosporidiosis)
- 8.8.9 Giardiasis and balantidiasis
- 8.8.10 <i>Blastocystis</i> infection
- 8.8.11 Human African trypanosomiasis
- 8.8.12 Chagas disease
- 8.8.13 Leishmaniasis
- 8.8.14 Trichomoniasis
- 8.9 Nematodes (roundworms)
- 8.10 Cestodes (tapeworms)
- 8.11 Trematodes (flukes)
- 8.12 Nonvenomous arthropods
- 8.13 Pentastomiasis (porocephalosis, linguatulosis/linguatuliasis, or tongue worm infection)
- Section 9 Sexually transmitted diseases
- Section 10 Environmental medicine, occupational medicine, and poisoning
- Section 11 Nutrition
- Section 12 Metabolic disorders
- Section 13 Endocrine disorders
- Section 14 Medical disorders in pregnancy
- Section 15 Gastroenterological disorders
- Section 16 Cardiovascular disorders
- Section 17 Critical care medicine
- Section 18 Respiratory disorders
- Section 19 Rheumatological disorders
- Section 20 Disorders of the skeleton
- Section 21 Disorders of the kidney and urinary tract
- Section 22 Haematological disorders
- Section 23 Disorders of the skin
- Section 24 Neurological disorders
- Section 25 Disorders of the eye
- Section 26 Psychiatric and drug-related disorders
- Section 27 Forensic medicine
- Section 28 Sport and exercise medicine
- Section 29 Biochemistry in medicine
- Section 30 Acute medicine